$GRPS
Trans American Aquaculture, Inc

2024 Q2 Form 10-Q Financial Statement

#000168316824005875 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023 Q2
Revenue
YoY Change
Cost Of Revenue $1.771K $0.00
YoY Change
Gross Profit $3.248K $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$206.6K -$120.6K
YoY Change 71.29%
Pretax Income -$330.3K -$296.1K
YoY Change 11.57%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$330.3K -$296.1K
YoY Change 11.57%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 1.417B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q4 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $6.600K $0.00
Short-Term Investments
Other Short-Term Assets $904.00 $0.00
YoY Change
Inventory $370.7K $247.4K
Prepaid Expenses
Receivables
Other Receivables $30.53K $0.00
Total Short-Term Assets $402.1K $254.0K
YoY Change 22.35%
LONG-TERM ASSETS
Property, Plant & Equipment $7.408M
YoY Change -0.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.385M $7.408M
YoY Change -0.73%
TOTAL ASSETS
Total Short-Term Assets $402.1K $254.0K
Total Long-Term Assets $7.385M $7.408M
Total Assets $7.787M $7.662M
YoY Change -0.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $379.3K $403.7K
YoY Change 80.66%
Accrued Expenses $789.3K
YoY Change 76.62%
Deferred Revenue
YoY Change
Short-Term Debt $1.047M $525.6K
YoY Change 60.88%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.578M $3.732M
YoY Change 38.34%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.222M $4.332M
YoY Change -5.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.578M $3.732M
Total Long-Term Liabilities $4.222M $4.332M
Total Liabilities $8.800M $8.065M
YoY Change 10.38%
SHAREHOLDERS EQUITY
Retained Earnings -$3.556M -$2.867M
YoY Change 210.64%
Common Stock $135.1K $100.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.012M -$402.7K $446.0K
YoY Change
Total Liabilities & Shareholders Equity $7.787M $7.662M
YoY Change -0.11%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023 Q2
OPERATING ACTIVITIES
Net Income -$330.3K -$296.1K
YoY Change 11.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
57318 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
GRPS Preferred Series D Stock Dividends
PreferredSeriesDStockDividends
0 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
1046872 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
4221525 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001990446
dei Entity Address Address Line1
EntityAddressAddressLine1
1022 Shadyside Lane
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75223
dei City Area Code
CityAreaCode
972
dei Local Phone Number
LocalPhoneNumber
358-6037
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1471954105 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6600 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
30526 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
370663 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
247825 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
904 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
402093 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
254425 usd
CY2024Q2 GRPS Land Property Plant And Equipment Gross
LandPropertyPlantAndEquipmentGross
7948040 usd
CY2023Q4 GRPS Land Property Plant And Equipment Gross
LandPropertyPlantAndEquipmentGross
7935824 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
563073 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
527827 usd
CY2024Q2 GRPS Land Property Plant And Equipment Net
LandPropertyPlantAndEquipmentNet
7384967 usd
CY2023Q4 GRPS Land Property Plant And Equipment Net
LandPropertyPlantAndEquipmentNet
7407997 usd
CY2024Q2 us-gaap Assets
Assets
7787060 usd
CY2024Q2 us-gaap Bank Overdrafts
BankOverdrafts
7976 usd
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
379332 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
480721 usd
GRPS Sales And Service
SalesAndService
0 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
1771 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56640
dei Entity Registrant Name
EntityRegistrantName
TRANS AMERICAN AQUACULTURE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
02-0685828
CY2023Q4 us-gaap Assets
Assets
7662422 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1005468 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
789265 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
509574 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
345826 usd
CY2024Q2 GRPS Due To Related Parties
DueToRelatedParties
1628784 usd
CY2023Q4 GRPS Due To Related Parties
DueToRelatedParties
1667985 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1046872 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
525609 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4578006 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3809406 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
4221525 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4332293 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4221525 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4332293 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1471954105 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1471954105 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1452655528 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1452655528 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
35 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
20 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135103 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
99980 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3555558 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2943231 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1012471 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-479277 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7787060 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7662422 usd
CY2024Q2 GRPS Sales And Service
SalesAndService
5019 usd
CY2023Q2 GRPS Sales And Service
SalesAndService
0 usd
GRPS Sales And Service
SalesAndService
315145 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
223299 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
3248 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
91846 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
126993 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
175472 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
321383 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
345575 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
700 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
700 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1750 usd
CY2024Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
65328 usd
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
-0 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
65974 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
-0 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
141238 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
121296 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
273520 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
237375 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-206566 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-120596 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-338795 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-235625 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-330311 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-296068 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-568332 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-581200 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26937 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-330311 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-296068 usd
us-gaap Net Income Loss
NetIncomeLoss
-568332 usd
us-gaap Net Income Loss
NetIncomeLoss
-554263 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000210
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.000210
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000211
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.000211
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1464250830 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1460261010 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
364274 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2023Q1 GRPS Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
250000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-258194 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
456080 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
286000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-296068 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
446011 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-479277 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21118 usd
CY2024Q1 GRPS Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-238021 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-696180 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14020 usd
CY2024Q2 GRPS Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-330311 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1012471 usd
us-gaap Net Income Loss
NetIncomeLoss
-568332 usd
us-gaap Net Income Loss
NetIncomeLoss
-554263 usd
us-gaap Depreciation
Depreciation
35246 usd
us-gaap Depreciation
Depreciation
38108 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
19012 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
100000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30526 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8038 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
122838 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
336672 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-0 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
26937 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
904 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-101391 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
107152 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
163750 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
0 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8038 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
216203 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
177735 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-389780 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-494877 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
12216 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
15132 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12216 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15132 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-288 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
7976 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
4541 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
31649 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
88700 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
70850 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
77684 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
32505 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
41260 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
443000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16127 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
-0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
8000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
544000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
395397 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
510010 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6600 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6600 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
23736 usd
GRPS Preferred Series D Stock Dividends
PreferredSeriesDStockDividends
43995 usd
GRPS Common Stock Issued For Services Rendered
CommonStockIssuedForServicesRendered
19012 usd
GRPS Common Stock Issued For Services Rendered
CommonStockIssuedForServicesRendered
100000 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2020 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
445500 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
155200 usd
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
33180 usd
CY2020Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
58300 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zT0XRyVnkRNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86F_zXe1Ta3JLXE1">Use of Estimates</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_z8f5z52QZ3nc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_zjCgUnrVXae5">Concentrations of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to credit risk consist primarily of temporary cash investments and accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.05pt">The Company maintains its cash balances at a large financial institution. At times such balances may exceed federally insured limits. The Company has not experienced any losses in an account. The Company believes it is not exposed to any significant credit risk on cash and had no balances in excess of the $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zhPhogujxkXc" title="FDIC limit">250,000</span> FDIC limit for the period ended June 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six months ended June 30, 2024 and 2023, two and one customer accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zeDD7ZA3ruc2" title="Concentration risk, percentage"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zslcFRf9cGsl" title="Concentration risk, percentage">100</span></span>% of total revenues earned.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s sole source of expected future revenue consists of the sale of a single live product which requires substantial care.  Production risks such as weather, disease and other factors could affect the Company’s ability to realize revenue from its inventory stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q2 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
12234 usd
CY2023Q4 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
191463 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
370663 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
247825 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1821798 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1809581 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
563073 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
527827 usd
CY2024Q2 GRPS Property Plant And Equipment Excluding Land Net
PropertyPlantAndEquipmentExcludingLandNet
1258725 usd
CY2023Q4 GRPS Property Plant And Equipment Excluding Land Net
PropertyPlantAndEquipmentExcludingLandNet
1281754 usd
CY2024Q2 us-gaap Land
Land
6126242 usd
CY2023Q4 us-gaap Land
Land
6126243 usd
CY2024Q2 GRPS Land Property Plant And Equipment Net
LandPropertyPlantAndEquipmentNet
7384967 usd
CY2023Q4 GRPS Land Property Plant And Equipment Net
LandPropertyPlantAndEquipmentNet
7407997 usd
us-gaap Depreciation
Depreciation
35246 usd
us-gaap Depreciation
Depreciation
38108 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
32397 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
36526 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
5268397 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
4857902 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
525609 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
4332293 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1046872 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
228765 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
242807 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
257801 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
273532 usd
CY2024Q2 GRPS Long Term Debt Maturities Repayments Of Principal In Year Four And Thereafter
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourAndThereafter
3218620 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
5268397 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
548375 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
419682 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
4728 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
9779 usd
CY2024Q2 GRPS Deferred Tax Assets Gross1
DeferredTaxAssetsGross1
543647 usd
CY2023Q4 GRPS Deferred Tax Assets Gross1
DeferredTaxAssetsGross1
409903 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
543647 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
409903 usd
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-0 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-0 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-26937 usd
CY2024Q1 us-gaap Shares Issued
SharesIssued
4615277 shares
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.00224
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2106 usd
CY2024Q2 us-gaap Shares Issued
SharesIssued
11683300 shares
CY2024Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.0012
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12715 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-005875-index-headers.html Edgar Link pending
0001683168-24-005875-index.html Edgar Link pending
0001683168-24-005875.txt Edgar Link pending
0001683168-24-005875-xbrl.zip Edgar Link pending
bml.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grps-20240630.xsd Edgar Link pending
image_002.jpg Edgar Link pending
image_007.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
grps-20240630_cal.xml Edgar Link unprocessable
grps-20240630_def.xml Edgar Link unprocessable
grps-20240630_lab.xml Edgar Link unprocessable
grps-20240630_pre.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
transaqua_ex0401.htm Edgar Link pending
transaqua_ex1001.htm Edgar Link pending
transaqua_ex1002.htm Edgar Link pending
transaqua_ex1003.htm Edgar Link pending
transaqua_ex3101.htm Edgar Link pending
transaqua_ex3102.htm Edgar Link pending
transaqua_ex3201.htm Edgar Link pending
transaqua_i10q-063024.htm Edgar Link pending
transaqua_i10q-063024_htm.xml Edgar Link completed